Literature DB >> 21813228

Proarrhythmic potential of amiodarone: an underestimated risk?

Alfonso Jurado Román, Belén Rubio Alonso, Roberto Martín Asenjo, Rafael Salguero Bodes, María López Gil, Fernando Arribas Ynsaurriaga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21813228     DOI： 10.1016/j.recesp.2011.05.014

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN： 1885-5857


× No keyword cloud information.
  3 in total

1.  The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker.

Authors:  Xiao-Fang Yang; Yong Yang; Yi-Tian Lian; Zhao-Hui Wang; Xiao-Wei Li; Long-Xian Cheng; Jin-Ping Liu; Yan-Fu Wang; Xiang Gao; Yu-Hua Liao; Min Wang; Qiu-Tang Zeng; Kun Liu
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

2.  Human In Silico Drug Trials Demonstrate Higher Accuracy than Animal Models in Predicting Clinical Pro-Arrhythmic Cardiotoxicity.

Authors:  Elisa Passini; Oliver J Britton; Hua Rong Lu; Jutta Rohrbacher; An N Hermans; David J Gallacher; Robert J H Greig; Alfonso Bueno-Orovio; Blanca Rodriguez
Journal:  Front Physiol       Date:  2017-09-12       Impact factor: 4.566

3.  Amiodarone in junctional ectopic tachycardia: A word of caution!

Authors:  Pooja Ahuja; Ashish Walian; Rohan Magoon; Ramesh Kashav
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2021-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.